TP53 and cancer: There is now evidence that several oncogenes or transcription factors critical for cancer progression, like loss of p53 (Contractor and Harris, 2012) or activation of hypoxia-inducible factor 1α (HIF1α; Kim et al., 2006), can induce PDK expression and thus inhibit PDH and GO.